194 related articles for article (PubMed ID: 33508760)
1. Optimization and method validation for the quantitative analysis of a monoclonal antibody and its related fab fragment in human plasma after intravitreal administration, using LC-MS/MS.
DelGuidice CE; Ismaiel OA; Mylott WR; Halquist MS
J Chromatogr B Analyt Technol Biomed Life Sci; 2021 Feb; 1164():122474. PubMed ID: 33508760
[TBL] [Abstract][Full Text] [Related]
2. Intact quantitative bioanalytical method development and fit-for-purpose validation of a monoclonal antibody and its related fab fragment in human vitreous and aqueous humor using LC-HRMS.
DelGuidice CE; Ismaiel OA; Mylott WR; Yuan M; Halquist MS
Anal Bioanal Chem; 2022 Jun; 414(14):4189-4202. PubMed ID: 35451621
[TBL] [Abstract][Full Text] [Related]
3. Comparison of methods for quantitative analysis of ranibizumab and bevacizumab in human plasma using various bioanalytical techniques, including microfluidic immunoassay, triple quadrupole, and high-resolution liquid chromatography-tandem mass spectrometry approaches.
DelGuidice CE; Ismaiel OA; Mylott WR; Halquist MS
J Pharm Biomed Anal; 2022 Aug; 217():114823. PubMed ID: 35576733
[TBL] [Abstract][Full Text] [Related]
4. LC-MS/MS determination of a human mAb drug candidate in rat serum using an isotopically labeled universal mAb internal standard.
Li W; Lin H; Fu Y; Flarakos J
J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Feb; 1044-1045():166-176. PubMed ID: 28113139
[TBL] [Abstract][Full Text] [Related]
5. Comparison of bioanalytical methods for the quantitation of PEGylated human insulin.
de Dios K; Manibusan A; Marsden R; Pinkstaff J
J Immunol Methods; 2013 Oct; 396(1-2):1-7. PubMed ID: 23933323
[TBL] [Abstract][Full Text] [Related]
6. Bioanalysis of therapeutic monoclonal antibody by peptide adsorption-controlled LC-MS.
Hashii N; Tousaka Y; Arai K; Enoki Y; Fukuda S; Goda R; Inoue N; Kawabata M; Murata K; Nakatsuji M; Okuzono T; Shigeyama T; Tachiki H; Yamaguchi T; Yamane S; Yamaoka M; Saito Y; Ishii-Watabe A
Bioanalysis; 2021 Feb; 13(4):265-276. PubMed ID: 33543661
[No Abstract] [Full Text] [Related]
7. Quantification of the anti-murine PD-1 monoclonal antibody RMP1-14 in BALB/c mouse plasma by liquid chromatography-tandem mass spectrometry and application to a pharmacokinetic study.
Agrawal K; Hill RC; Wilkinson BL; Allison PB; Thomas CE
Anal Bioanal Chem; 2020 Jan; 412(3):739-752. PubMed ID: 31832706
[TBL] [Abstract][Full Text] [Related]
8. LC-MS/MS quantification of free and Fab-bound colchicine in plasma, urine and organs following colchicine administration and colchicine-specific Fab fragments treatment in Göttingen minipigs.
Fabresse N; Allard J; Sardaby M; Thompson A; Clutton RE; Eddleston M; Alvarez JC
J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Aug; 1060():400-406. PubMed ID: 28667924
[TBL] [Abstract][Full Text] [Related]
9. Vitreomacular Interface after Anti-Vascular Endothelial Growth Factor Injections in Neovascular Age-Related Macular Degeneration.
Veloso CE; Kanadani TM; Pereira FB; Nehemy MB
Ophthalmology; 2015 Aug; 122(8):1569-72. PubMed ID: 26038338
[TBL] [Abstract][Full Text] [Related]
10. Multiplexed monitoring of therapeutic antibodies for inflammatory diseases using Fab-selective proteolysis nSMOL coupled with LC-MS.
Iwamoto N; Takanashi M; Yokoyama K; Yonezawa A; Denda M; Hashimoto M; Tanaka M; Ito H; Matsuura M; Yamamoto S; Honzawa Y; Matsubara K; Shimada T
J Immunol Methods; 2019 Sep; 472():44-54. PubMed ID: 31201793
[TBL] [Abstract][Full Text] [Related]
11. Two validated liquid chromatography-mass spectrometry methods with different pretreatments for the quantification of an anti-CD47 monoclonal antibody in rat and cynomolgus monkey serum compared with an electrochemiluminescence method.
Gao Y; Zhang D; Yang C; Duan X; Li X; Zhong D
J Pharm Biomed Anal; 2019 Oct; 175():112792. PubMed ID: 31377653
[TBL] [Abstract][Full Text] [Related]
12. A method combining blue native polyacrylamide gel electrophoresis with liquid chromatography tandem-mass spectrometry to detect circulating immune complexes between therapeutic monoclonal antibodies and anti-drug antibodies in animals.
Kobayashi K; Tahara H; Kagawa Y
J Pharm Biomed Anal; 2020 Jul; 186():113329. PubMed ID: 32371323
[TBL] [Abstract][Full Text] [Related]
13. Application of in-sample calibration curve methodology for regulated bioanalysis: Critical considerations in method development, validation and sample analysis.
Yuan L; Gu H; Zeng J; Pillutla RC; Ji QC
J Pharm Biomed Anal; 2020 Jan; 177():112844. PubMed ID: 31491659
[TBL] [Abstract][Full Text] [Related]
14. Use of an alternative signature peptide during development of a LC-MS/MS assay of plasma nivolumab levels applicable for multiple species.
Ohuchi M; Yagishita S; Taguchi K; Goto Y; Fukahori M; Enoki Y; Shimada T; Yamaguchi M; Matsumoto K; Hamada A
J Chromatogr B Analyt Technol Biomed Life Sci; 2021 Jan; 1162():122489. PubMed ID: 33385769
[TBL] [Abstract][Full Text] [Related]
15. Progress in high-sensitivity hybrid LC-MS/MS methods for the bioanalysis of protein drugs and performance tests for their validation.
Duggan JX
Bioanalysis; 2018 Jul; 10(13):983-986. PubMed ID: 29993264
[No Abstract] [Full Text] [Related]
16. Validated LC-MS/MS analysis of immune checkpoint inhibitor Nivolumab in human plasma using a Fab peptide-selective quantitation method: nano-surface and molecular-orientation limited (nSMOL) proteolysis.
Iwamoto N; Shimada T; Terakado H; Hamada A
J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Jun; 1023-1024():9-16. PubMed ID: 27155936
[TBL] [Abstract][Full Text] [Related]
17. A new reliable, transposable and cost-effective assay for absolute quantification of total plasmatic bevacizumab by LC-MS/MS in human plasma comparing two internal standard calibration approaches.
Legeron R; Xuereb F; Chaignepain S; Gadeau AP; Claverol S; Dupuy JW; Djabarouti S; Couffinhal T; Schmitter JM; Breilh D
J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Dec; 1070():43-53. PubMed ID: 29111437
[TBL] [Abstract][Full Text] [Related]
18. Comparison of Bevacizumab Quantification Results in Plasma of Non-small Cell Lung Cancer Patients Using Bioanalytical Techniques Between LC-MS/MS, ELISA, and Microfluidic-based Immunoassay.
Iwamoto N; Takanashi M; Shimada T; Sasaki J; Hamada A
AAPS J; 2019 Aug; 21(6):101. PubMed ID: 31432293
[TBL] [Abstract][Full Text] [Related]
19. Immunoaffinity LC-MS/MS to quantify a PEGylated anti-Factor D Fab biotherapeutic in cynomolgus monkey serum.
Liu L; Liu Y; Dai L; Stella C; Faria M; Shao J; Hicks JL; Cortes DF; Mylott WR; Wakshull E; Kaur S; Xu K
Bioanalysis; 2019 Dec; 11(23):2161-2173. PubMed ID: 31701759
[No Abstract] [Full Text] [Related]
20. Liquid chromatography coupled with tandem mass spectrometry for the bioanalysis of proteins in drug development: practical considerations in assay development and validation.
Liu G; Ji QC; Dodge R; Sun H; Shuster D; Zhao Q; Arnold M
J Chromatogr A; 2013 Apr; 1284():155-62. PubMed ID: 23466204
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]